Employees Retirement System of Texas’s Sarepta Therapeutics SRPT Stock Holding History

Employees Retirement System of Texas’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-23,000	Closed	-$1.72M	–	634
2022 Q2	$1.72M	Hold	23,000	–	–	0.02%	534
2022 Q1	$1.8M	Buy	23,000 +12,000	+109%	+$919K	0.02%	579
2021 Q4	$991K	Buy	11,000 +2,147	+24%	+$184K	0.01%	655
2021 Q3	$819K	Hold	8,853	–	–	0.01%	716
2021 Q2	$688K	Hold	8,853	–	–	0.01%	698
2021 Q1	$660K	Buy	+8,853	New	+$817K	0.01%	698
2020 Q4	–	Sell	-8,853	Closed	-$1.24M	–	722
2020 Q3	$1.24M	Hold	8,853	–	–	0.02%	604
2020 Q2	$1.42M	Hold	8,853	–	–	0.02%	565
2020 Q1	$866K	Hold	8,853	–	–	0.02%	613
2019 Q4	$1.14M	Hold	8,853	–	–	0.02%	675
2019 Q3	$667K	Buy	+8,853	New	+$1.05M	0.01%	781

Other funds holding SRPT

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Employees Retirement System of Texas's SRPT Position: Q3 2022 in Review

Employees Retirement System of Texas sold out of Sarepta Therapeutics (SRPT) in Q3 2022, closing a stake of 23,000 shares — an estimated $1.72M sold.

Employees Retirement System of Texas first reported a position in SRPT in Q3 2019 and held it in 11 quarters. The position peaked at $1.8M in Q1 2022. 376 funds tracked by Wall St. Rank hold SRPT as of Q3 2022.

Employees Retirement System of Texas reported no remaining Sarepta Therapeutics position as of Q3 2022 after selling out during the quarter.
Employees Retirement System of Texas sold 23,000 Sarepta Therapeutics shares in Q3 2022, an estimated $1.72M.
Employees Retirement System of Texas first reported a position in Sarepta Therapeutics in Q3 2019 and held it in 11 quarters.
Employees Retirement System of Texas's Sarepta Therapeutics position peaked at $1.8M in Q1 2022.
376 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2022.

Based on Employees Retirement System of Texas's 13F filing for Q3 2022, filed 10 Nov 2022.